[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367782-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-367782-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","cold-inducible-rna-binding-protein-is-associated-with-subtype-specific-breast-cancer-patient-outcomes","Cold-inducible RNA-binding protein is associated with subtype-specific breast cancer patient outcomes","","Cold-inducible RNA-binding protein (CIRBP) is a stress-induced mRNA-binding protein linked to clinical outcomes across diseases, but its prognostic value in breast cancer was not established. An annotated tissue micro-array cohort examined 1406 hormone receptor–positive and 281 triple-negative primary tumors using immunohistochemistry and survival statistics. Results show high CIRBP correlates with poor overall and progression-free survival in TNBC, while HR+ cases show a favorable association. Findings support CIRBP’s biomarker role with subtype-specific effects.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cold-inducible-rna-binding-protein-is-associated-with-subtype-specific-breast-cancer-patient-outcomes/367782/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cold-inducible-rna-binding-protein-is-associated-with-subtype-specific-breast-cancer-patient-outcomes/367782.png","ImageObject",300,407,{"name":42,"@type":43},"Mimi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is CIRBP and why was it studied in breast cancer?","Question",{"text":63,"@type":64},"CIRBP is a stress-induced mRNA-binding protein. Its role as a prognostic biomarker in breast cancer had not been established prior to this work.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was CIRBP measured in the patient cohorts?",{"text":68,"@type":64},"The study stained clinically annotated tissue micro-array samples from 1406 HR+ and 281 triple-negative primary breast cancers using immunohistochemistry (IHC) for CIRBP expression.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the prognostic association of CIRBP in TNBC versus HR+ breast cancer?",{"text":72,"@type":64},"In TNBC, high CIRBP expression by IHC was associated with poor overall survival and progression-free survival in multivariate analysis. In HR+ breast cancer, CIRBP expression was correlated with favorable overall and progression-free survival.",{"name":74,"@type":61,"acceptedAnswer":75},"Which statistical methods were used to analyze outcomes?",{"text":76,"@type":64},"Kaplan–Meier estimator was used for survival evaluation, along with univariate and multivariate Cox proportional hazards models incorporating tumor size, lymph node status, grade, and CIRBP expression.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},367782,1790277919,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Dankner etal. Breast Cancer Research (2025) 27:149  \n[https://doi.org/10.1186/s13058-025-02098-3](https://doi.org/10.1186/s13058-025-02098-3)  \nBreast Cancer Research  \n BRIEF REPORT Open Access  \nCold-inducible RNA-binding protein is associated with subtype-specific breast cancer patient outcomes  \nMatthew Dankner1,2, Veronique Ouellet3, Jakob Lafon2, Rima Ezzeddine 1,4, Matthew G. Annis 1,2, Afnan Abu-Thuraia1,4, Quebec Breast Cancer Foundation Tissue Microarray Consortium5 and Peter M. Siegel 1,2,4*  \nAbstract  \nBackground Cold-inducible RNA-binding protein (CIRBP) is a stress-induced mRNA-binding protein associated with clinical outcomes in a variety of human disease states. The role of CIRBP as a role as a prognostic biomarker in breast cancer (BC) has yet to be established.  \nFindings We describe a clinically annotated tissue micro-array cohort of 1406 hormone receptor positive (HR +) and 281 triple negative primary breast cancers (TNBC) stained by immunohistochemistry (IHC) for CIRBP. Statistical analyses were performed with the Kaplan–Meier estimator, as well as univariate and multivariate Cox proportionalhazards models. Multivariate models incorporated tumor size, lymph node status, grade and CIRBP expression levels. Co-primary endpoints were overall survival (OS) and progression-free survival (PFS) . In N = 281 primary TNBCs, high levels of CIRBP expression by IHC was associated with poor prognosis in multivariate analysis (OS: adjusted hazard ratio (aHR) 2. 05, 95% confidence interval (CI) 1.24–3.41, P = 0.005. PFS: aHR 2 .46, 95% CI 1.33–4. 57, P = 0 . 004) . However, in N = 1406 HR + primary BC, CIRBP expression was correlated with favorable prognosis (OS: aHR 0 . 927, 95% CI 0.88– 0. 98, P = 0.005. PFS: aHR 0 . 904, 95% CI 0.85–0. 96, P = 0 . 002) .  \nConclusions CIRBP expression is associated with poor prognosis inTNBC but not HR + BC patients. This finding highlights the prognostic significance of CIRBP inTNBC and suggests differential underlying mRNA targets bound and modulated by CIRBP inTNBC and HR + BC, respectively.  \nKeywords CIRBP, Breast cancer, TNBC, Estrogen receptor, Biomarker  \n*Correspondence: Peter M. Siegel [peter.siegel@mcgill.ca](peter.siegel@mcgill.ca)  \n1 Rosalind and Morris Goodman Cancer Institute, 1160 Pine Avenue West, Rm 513, Montréal, Québec H3A 1A3, Canada  \n2 Department of Medicine, McGill University, Montréal, Québec, Canada  \n3 Centre de Recherche, Centre Hospitalier de L’Université de Montréal, Montréal, Québec, Canada  \n4 Department of Biochemistry, Montréal, Québec, Canada  \n5 Québec Breast Cancer Foundation, Québec City, Québec, Canada  \nMain text  \nCold-inducible RNA-binding protein (CIRBP) is an mRNA binding protein that functions by stabilizing mRNA transcripts associated with adaptation to cellular stressors [1] . CIRBP controls the response to a variety of stress stimuli, such as cold-shock, hypoxia and ultraviolet radiation [1] . Overexpression of CIRBP is associated with poor prognosis in multiple cancer types, such as oral squamous cell carcinoma, pituitary adenoma, and hepatocellular carcinoma [1] . In contrast, CIRBP expression has been associated with favourable prognosis in  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your inten","cbCaic8OWcDPLjFB","https://ap.wps.com/l/cbCaic8OWcDPLjFB","pdf",1292866,17,"English","# Abstract\n# Findings\n## Patient cohorts and staining\n## Survival analysis and hazard ratios\n# Conclusions\n# Keywords","[{\"question\":\"What is CIRBP and why was it studied in breast cancer?\",\"answer\":\"CIRBP is a stress-induced mRNA-binding protein. Its role as a prognostic biomarker in breast cancer had not been established prior to this work.\"},{\"question\":\"How was CIRBP measured in the patient cohorts?\",\"answer\":\"The study stained clinically annotated tissue micro-array samples from 1406 HR+ and 281 triple-negative primary breast cancers using immunohistochemistry (IHC) for CIRBP expression.\"},{\"question\":\"What is the prognostic association of CIRBP in TNBC versus HR+ breast cancer?\",\"answer\":\"In TNBC, high CIRBP expression by IHC was associated with poor overall survival and progression-free survival in multivariate analysis. In HR+ breast cancer, CIRBP expression was correlated with favorable overall and progression-free survival.\"},{\"question\":\"Which statistical methods were used to analyze outcomes?\",\"answer\":\"Kaplan–Meier estimator was used for survival evaluation, along with univariate and multivariate Cox proportional hazards models incorporating tumor size, lymph node status, grade, and CIRBP expression.\"}]","Cold-inducible RNA-binding protein is associated with subtype-specific breast cancer patient outcomes | PDF",1790172589,43,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee4b28548d9f50df869d5da5f7a7e055.webp",983,1305,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a609a8fe29cd5734e773518a3936e9fe.webp",982,1304,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b6b34a7362d2751223210e6306de11a.webp",981,1303,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f245d0ca2ff601052321d40a6866bb6.webp",980,1301]